Pettinga Financial Advisors LLC Makes New $238,000 Investment in KKR & Co. Inc. (NYSE:KKR)

Pettinga Financial Advisors LLC purchased a new stake in KKR & Co. Inc. (NYSE:KKR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,821 shares of the asset manager’s stock, valued at approximately $238,000.

A number of other institutional investors also recently modified their holdings of KKR. Advisor Resource Council bought a new stake in KKR & Co. Inc. during the 1st quarter valued at $1,001,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of KKR & Co. Inc. by 352.6% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 143,610 shares of the asset manager’s stock valued at $14,444,000 after purchasing an additional 111,881 shares during the period. Janney Montgomery Scott LLC lifted its holdings in KKR & Co. Inc. by 6.8% during the 1st quarter. Janney Montgomery Scott LLC now owns 100,550 shares of the asset manager’s stock worth $10,113,000 after purchasing an additional 6,406 shares in the last quarter. Sei Investments Co. lifted its holdings in KKR & Co. Inc. by 19.9% during the 1st quarter. Sei Investments Co. now owns 1,037,530 shares of the asset manager’s stock worth $104,355,000 after purchasing an additional 171,902 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in KKR & Co. Inc. by 42.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 41,814 shares of the asset manager’s stock worth $4,206,000 after purchasing an additional 12,504 shares during the period. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The shares were bought at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the purchase, the insider now directly owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on KKR shares. The Goldman Sachs Group increased their price target on shares of KKR & Co. Inc. from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Friday. Keefe, Bruyette & Woods reiterated an “outperform” rating and issued a $144.00 target price (up from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft raised their price target on shares of KKR & Co. Inc. from $128.00 to $141.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Morgan Stanley upped their price target on shares of KKR & Co. Inc. from $107.00 to $143.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Finally, Hsbc Global Res raised KKR & Co. Inc. to a “strong-buy” rating in a report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, KKR & Co. Inc. has a consensus rating of “Moderate Buy” and an average target price of $151.29.

KKR & Co. Inc. Trading Down 2.4 %

NYSE:KKR opened at $139.88 on Friday. The company has a 50-day moving average price of $128.49 and a 200-day moving average price of $114.00. The stock has a market cap of $124.14 billion, a price-to-earnings ratio of 32.99, a P/E/G ratio of 1.20 and a beta of 1.62. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. KKR & Co. Inc. has a 12 month low of $53.72 and a 12 month high of $147.15.

KKR & Co. Inc. (NYSE:KKR) last issued its quarterly earnings data on Wednesday, July 31st. The asset manager reported $1.09 EPS for the quarter, topping the consensus estimate of $0.89 by $0.20. The business had revenue of $4.17 billion during the quarter, compared to analyst estimates of $1.07 billion. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. During the same period last year, the business posted $0.58 earnings per share. Equities analysts predict that KKR & Co. Inc. will post 3.97 EPS for the current year.

KKR & Co. Inc. Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be paid a $0.175 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $0.70 annualized dividend and a yield of 0.50%. KKR & Co. Inc.’s payout ratio is 16.51%.

About KKR & Co. Inc.

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.